Patents by Inventor Nina Meissler

Nina Meissler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11971407
    Abstract: An in vitro method is disclosed for detecting an antibody to p53 (anti-p53 antibody) in a sample, the method comprising: incubating a sample to be analyzed with a p53 capture antigen and a p53 detection antigen, whereby a complex comprising the p53 capture antigen, the anti-p53 antibody and the p53 detection antigen is formed, separating the complex formed from unbound detection antigen and measuring the complex obtained via the detection antigen comprised therein, thereby detecting the anti-p53 antibody comprised in the sample.
    Type: Grant
    Filed: April 27, 2022
    Date of Patent: April 30, 2024
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Herbert Andres, Johann Karl, Ursula Kunert, David Morgenstern, Nina Meissler, Marion Niessner, Magdalena Swiatek-de Lange
  • Publication number: 20220252592
    Abstract: The disclosure relates to an in vitro method for detecting an antibody to p53 (anti-p53 antibody) in a sample, the method comprising: incubating a sample to be analyzed with a p53 capture antigen and a p53 detection antigen, whereby a complex comprising the p53 capture antigen, the anti-p53 antibody and the p53 detection antigen is formed, separating the complex formed from unbound detection antigen and measuring the complex obtained via the detection antigen comprised therein, thereby detecting the anti-p53 antibody comprised in the sample.
    Type: Application
    Filed: April 27, 2022
    Publication date: August 11, 2022
    Inventors: Herbert Andres, Johann Karl, Ursula Kunert, David Morgenstern, Nina Meissler, Marion Niessner, Magdalena Swiatek-de Lange
  • Publication number: 20180364230
    Abstract: The disclosure relates to an in vitro method for detecting an antibody to p53 (anti-p53 antibody) in a sample, the method comprising: incubating a sample to be analyzed with a p53 capture antigen and a p53 detection antigen, whereby a complex comprising the p53 capture antigen, the anti-p53 antibody and the p53 detection antigen is formed, separating the complex formed from unbound detection antigen and measuring the complex obtained via the detection antigen comprised therein, thereby detecting the anti-p53 antibody comprised in the sample.
    Type: Application
    Filed: August 24, 2018
    Publication date: December 20, 2018
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Herbert Andres, Johann Karl, Ursula Kunert, David Morgenstern, Nina Meissler, Marion Niessner, Magdalena Swiatek-de Lange